Safety and Efficacy of External Beam Radiation Therapy in Hepatocellular Carcinoma Patients Previously Treated With Yttrium 90 Transarterial Radioembolization
EBRT for HCC patients previously treated with yttrium 90 is feasible and offers excellent local control. Liver dysfunction and biliary toxicities are potential complications and should be weighed against the clinical benefits.
Authors
- Kanokphorn Thonglert
- Matthew J. Nyflot (ORCID: https://orcid.org/0000-0002-2356-9422)
- Wayne L. Monsky (ORCID: https://orcid.org/0000-0003-0694-6502)
- S. Apisarnthanarax
- Peter Zaki (ORCID: https://orcid.org/0000-0002-7451-4712)
- Guy E. Johnson (ORCID: https://orcid.org/0000-0002-0014-6136)
- Clemens Grassberger (ORCID: https://orcid.org/0000-0002-4425-4489)
- Stephen R. Bowen (ORCID: https://orcid.org/0000-0001-7581-770X)
- Joseph Tsai (ORCID: https://orcid.org/0000-0002-3533-4508)
- Yulun He
- August C Anderson
Institutions
- Thai Red Cross Society (TH)
- Chulalongkorn University (TH)
- University of Washington (US)
- King Chulalongkorn Memorial Hospital (TH)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2025-12-27
- DOI
- https://doi.org/10.1016/j.adro.2025.101984
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00